Liste-antineoplast_parenteral-black-18-06-2013

More documents

Recommendations

Info

Wirkstoff ATC-Code Standardaggregat FAM-Name Drf Doxorubicin HCL Oncotrade Doxorubicin HCL TEVA Doxorubicin- Actavis 2mg/ml 10 mlKonz.z.Her.Inf.lsg 20mg Doxorubicin- Actavis 2mg/ml 5 ml Konz.z.Her.Inf.lsg 10mg Doxorubicin- Actavis 2mg/ml Konz.z.Her.Inf.L.50mg 25 ml Doxorubicin- Actavis 2mg/ml Konz.z.Her.Inf.L200mg 100 ml Doxorubicin HCL Oncotrade 200 mg Injektionslösung Doxorubicin HCL Oncotrade 50 mg Injektionslösung Doxorubicin HCL TEVA 2mg/ml Konz.z.Her.Inf.lsg 10ml Doxorubicin HCL TEVA 2mg/ml Konz.z.Her.Inf.lsg 25ml Doxorubicin HCL TEVA 2mg/ml Konz.z.Her.Inf.lsg 5ml Doxorubicin HCL TEVA 2mg/ml Konz.z.Her.Inf.lsg100ml IFK IFK IFK IFK ILO ILO IFK IFK IFK IFK Doxorubicin HEXAL Doxorubicin 10 HEXAL 5 ml ILO Doxorubicin NC/ KL NC Doxorubicin accord Doxorubicin 100 Hexal 50 ml Doxorubicin 200 Hexal 100 ml Doxorubicin 50 HEXAL 25 ml Doxorubicin 50 HEXAL Inj. + Blaseninst.System 25 ml Doxorubicin 50 Hexal Doxorubicin NC 10 mg 5 ml Doxorubicin NC 100 mg 50 ml Doxorubicin NC 50 mg 25 ml Doxorubicin Accord 2mg/ml Konz.z.Her.Inf.Lsg.10mg Doxorubicin Accord 2mg/ml Konz.z.Her.Inf.Lsg.200mg Doxorubicin Accord 2mg/ml Konz.z.Her.Inf.Lsg.50mg Doxorubicin accord 2mg/ml Konz.z.Her.Inf.Lsg 10mg Doxorubicin accord 2mg/ml Konz.z.Her.Inf.Lsg 200mg Doxorubicin accord 2mg/ml Konz.z.Her.Inf.Lsg 50mg ILO ILO ILO ILO ILO IFK IFK IFK IFK IFK IFK IFK IFK IFK Myocet Myocet 2 Sets a 50 mg Haemato-Ph. TRS Seite 22 von 46
Wirkstoff ATC-Code Daunorubicin L01DB02 Epirubicin L01DB03 Standardaggregat FAM-Name Drf Myocet 2 Sets a 50 mg Tr.Subst.m.Lsg.M. Kohl Ph. Myocet 2 Sets a 50 mg m.Lsg.m CC Ph. Myocet Set A 50 mg Trockensubstanz mit Loesungsm. Myocet Set A 50 mg Trockensubstanz mit Loesungsm. Haemat Myocet Set A 50 mg Trockensubstanz mit Lösungsm. Tisida Myocet Set A 50 mg Trockensubstanz mit loesungsm. CC Ph. Myocet Set A 50 mg m.Lsg.M TRS TRS TRS TRS TRS TRS TRS Ribodoxo L 10/50 Ribodoxo L 10 IIL Ribodoxo L 50 IIL AV Ribodoxo L 50 DFL AV Daunoblastin Daunoblastin 20 mg TSS Axirubicin E Axirubicin E 2mg/ml 200 mg ILO Axirubicin E 2mg/ml 50 mg ILO Bendaepi Bendaepi 2 mg/ml 100 ml 200 mg ILO Bendaepi 2 mg/ml 25 ml 50 mg Bendaepi 2 mg/ml 50 ml 100 mg ILO ILO EPI-cell Epi-Cell 10 mg ILO Epi-Cell 20 mg Epi-Cell 200 mg Epi-Cell 50 mg ILO ILO ILO Epi NC Epi NC 10 mg Inf.-lsg.konz. 5ml IFK Epi NC 100 mg Inf.-lsg.konz. 50ml Epi NC 200 mg Inf.-lsg.konz.100ml Epi NC 50 mg Inf.-lsg.konz.25ml IFK IFK IFK Epi TEVA Epi TEVA 2 mg/ml Inj./Inf.Lsg. 10 ml DFL Epi TEVA 2 mg/ml Inj./Inf.Lsg. 100ml Epi TEVA 2 mg/ml Inj./Inf.Lsg. 25ml Epi TEVA 2 mg/ml Inj./Inf.Lsg. 5 ml Epi TEVA 2 mg/ml inj.o.inf.lsg. 75ml DFL DFL DFL DFL Epimedac Epimedac 10 mg 5 ml ILO Epimedac 100 mg 50 ml Epimedac 20 mg 10 ml Epimedac 200 mg 100 ml Epimedac 50 mg 25 ml ILO ILO ILO ILO Epirubicin Actavis Epirubicin Actavis 2mg/ml 100mg 50 ml ILO Seite 23 von 46
Page 1 and 2: Liste parenteraler antineoplastisch
Page 3 and 4: Wirkstoff ATC-Code Mitobronitol L01
Page 5 and 6: Cladribin L01BB04 Fludarabin L01BB0
Page 7 and 8: Tegafur L01BC03 Carmofur L01BC04 Ge
Page 9 and 10: Wirkstoff ATC-Code Standardaggregat
Page 11 and 12: Wirkstoff ATC-Code Fluorouracil, Ko
Page 13 and 14: Teniposid L01CB02 Demecolcin L01CC0
Page 17 and 18: Docetaxel L01CD02 Wirkstoff ATC-Cod
Page 21: Wirkstoff ATC-Code Doxorubicin L01D
Page 27 and 28: Pirarubicin L01DB08 Valrubicin L01D
Page 29 and 30: Carboplatin L01XA02 Wirkstoff ATC-C
Page 37 and 38: Wirkstoff ATC-Code Trastuzumab L01X
Page 39 and 40: Wirkstoff ATC-Code Methoxsalen L01X
Page 41 and 42: Tiazofurin L01XX18 Irinotecan L01XX
Page 45 and 46: Wirkstoff ATC-Code Arsentrioxid L01

Liste-antineoplast_parenteral-black-18-06-2013

Create successful ePaper yourself

Delete template?

Save as template?